Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Therapeutic Advances in Medical Oncology, 2024Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response
Hong M., Lee S., Cho B. et al.
Olink Target 96
Frontiers in Immunology, 2024The predictive value of TNF family for pulmonary tuberculosis: a pooled causal effect analysis of multiple datasets
Mo W., Cui Z., Zhao J. et al.
Nature Communications, 2024Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis
Chitnis T., Qureshi F., Gehman V. et al.
iScience, 2024Assessment of circulating proteins in thyroid cancer: Proteome-wide Mendelian randomization and colocalization analysis
Fan Q., Wen S., Zhang Y. et al.
Olink Explore 3072/384
Epigenomics, 2024Cell-free DNA methylation patterns in aging and their association with inflamm-aging
Li S., Gao X., Wang Z. et al.
Journal of Proteomics, 2024Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease
Pierre N., Huynh-Thu V., Baiwir D. et al.
Olink Target 48
European Heart Journal - Cardiovascular Pharmacotherapy, 2024Utilizing genetics and proteomics to assess the role of antihypertensive drugs in human longevity and the underlying pathways: a Mendelian randomization study
Fan B., Zhao J.
Obesity, 2024Altered proteome profiles related to visceral adiposity may mediate the favorable effect of green Mediterranean diet: the DIRECT‐PLUS trial
Zelicha H., Kaplan A., Yaskolka Meir A. et al.
Cancer Immunology Research, 2024PVRIG is Expressed on Stem-Like T Cells in Dendritic Cell–Rich Niches in Tumors and Its Blockade May Induce Immune Infiltration in Non-Inflamed Tumors
Alteber Z., Cojocaru G., Granit R. et al.
Circulation: Genomic and Precision Medicine, 2024Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction
van Blokland I., Oelen R., Groot H. et al.
Nature Communications, 2024Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment
Lu I., Cheung P., Heming M. et al.
Cell Genomics, 2024Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohorts
Lyu J., Jiang M., Zhu Z. et al.
Nature Communications, 2024Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank
Papier K., Atkins J., Tong T. et al.
Frontiers in Psychiatry, 2024Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
Sokolov A., Lafta M., Nordberg D. et al.
EMBO Molecular Medicine, 2024Electron transport chain capacity expands yellow fever vaccine immunogenicity
Mok D., Tng D., Yee J. et al.
Journal of the Neurological Sciences, 2024Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation
Jakimovski D., Qureshi F., Ramanathan M. et al.
Olink Focus
JAMA Network Open, 2024Cord Blood Proteomic Profiles, Birth Weight, and Early Life Growth Trajectories
Van Pee T., Martens D., Alfano R. et al.
Alzheimer's Research & Therapy, 2024Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy
Vervuurt M., Kuiperij H., de Kort A. et al.
Clinical and Translational Medicine, 2024Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
Man X., Huang J., Sun S. et al.
JHLT Open, 2024Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis
Dalsgaard R., Clemmensen T., Eiskjær H. et al.
3119 publications
Items per page
1001-1020 of 3119 publications